skip to content

Cambridge Stem Cell Institute


The Cambridge Stem Cell Institute supports local and national activity in the biomedical application of pluripotent stem cells with the UKRMP Pluripotent Stem Cells and Engineered Cells (PSEC) hub. 

Human pluripotent stem cells and regenerative medicine hold significant promise for a range of diseases, such as Parkinson's disease, liver disease and macular degeneration.

PSEC aims to advance regenerative medicine by overcoming the key outstanding hurdles to translate human Pluripotent Stem Cell (hPSC) based cellular therapies into standard clinical practice.

Using innovative, multidisciplinary approaches, the Hub aims to accelerate and streamline the process of translating hPSC-based therapies to the clinic and enabling their commercial development.


  • Roger Barker, Director
  • Zoe Hewitt, Project Manager, University of Sheffield
  • Cedric Ghevaert, Florian Merkle and Serena Nik-Zaina, Co-Investigators - University of Cambridge
  • Ivana Barbaric - University of Sheffield
  • Robert Thomas - Loughborough University

Research Team

  • Venkat Pisupati - University of Cambridge
  • Dylan Stavish, Duncan Baker - University of Sheffield
  • Preeti Holland - Loughborough University
  • Christopher Price - University of Sheffield 


  • Jo Jones - University of Cambridge
  • Stuart Forbes - University of Edinburgh 
  • Waseem Qasim - University College London